Literature DB >> 2785531

Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus.

J Bentin1, C D Tsoukas, J A McCutchan, S A Spector, D D Richman, J H Vaughan.   

Abstract

Uncertainty has existed as to whether a T-cell deficiency exists in human immunodeficiency virus (HIV) infection different from that inherent in the reduced T-cell numbers characteristic of the disease. Heretofore, methods for measuring T-cell responses in patients have been carried out with systems requiring monocytes as accessory cells. In the presence of high concentrations of interleukin-2, however, highly purified T cells respond in a monocyte-independent fashion to antibody reactive with the CD3 component of the antigen receptor complex Ti/CD3. Highly purified T cells of HIV-infected patients responded subnormally in this anti-CD3/IL-2 system, even in the case of patients who were asymptomatic or had only lymphadenopathy. The defective T-cell responses occurred over a wide range of concentrations of the anti-CD3. Neither poor IL-2 receptor function as reflected by responses to limiting dilutions of IL-2 nor IL-1 receptor function as defined by incremental proliferation when IL-1 is added accounted for this defect, which also correlated poorly with T4 and T8 numbers. These results suggested that the T-cell abnormality was closely related to Ti/CD3 function, was not specifically or restrictively associated with T4 cells, and was not due to defective IL-2- or IL-1-receptor functions. The amount of HIV RNA in 10(5) T lymphocytes from the patients amounted to less than that found in one cell of a standard HIV infected laboratory cell line (CEM), using slot-blot hybridization. Thus the T-cell deficiency we have observed was not likely to be due directly to cell killing by HIV resident in the T4 cells. Other factors may be important in inducing the immunodeficiency, some of which are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785531     DOI: 10.1007/bf00916944

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  63 in total

1.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

2.  Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine.

Authors:  J Bentin; D A Carson; J H Vaughan; C D Tsoukas
Journal:  Transplantation       Date:  1986-09       Impact factor: 4.939

3.  DNA strand breaks, NAD metabolism, and programmed cell death.

Authors:  D A Carson; S Seto; D B Wasson; C J Carrera
Journal:  Exp Cell Res       Date:  1986-06       Impact factor: 3.905

4.  Study of activated T cells in man. II. Interleukin 2 receptor and transferrin receptor expression on T cells and production of interleukin 2 in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex.

Authors:  S Gupta
Journal:  Clin Immunol Immunopathol       Date:  1986-01

5.  Immunoregulatory lymphokines of T hybridomas from AIDS patients: constitutive and inducible suppressor factors.

Authors:  J Laurence; L Mayer
Journal:  Science       Date:  1984-07-06       Impact factor: 47.728

6.  Autologous mixed lymphocyte reaction in man. XIV. Deficiency of the autologous mixed lymphocyte reaction in acquired immune deficiency syndrome (AIDS) and AIDS related complex (ARC). In vitro effect of purified interleukin-1 and interleukin-2.

Authors:  S Gupta; S Gillis; M Thornton; M Goldberg
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

7.  Clonal analysis of T lymphocytes in the acquired immunodeficiency syndrome. Evidence for an abnormality affecting individual helper and suppressor T cells.

Authors:  J B Margolick; D J Volkman; H C Lane; A S Fauci
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

8.  Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders.

Authors:  J L Fahey; H Prince; M Weaver; J Groopman; B Visscher; K Schwartz; R Detels
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

Review 9.  Mechanisms of T-cell functional deficiency in the acquired immunodeficiency syndrome.

Authors:  G V Quinnan; J P Siegel; J S Epstein; J F Manischewitz; S Barnes; M A Wells
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

10.  Immunological studies in the acquired immunodeficiency syndrome. II. Active suppression or intrinsic defect--investigated by mixing AIDS cells with HLA-DR identical normal cells.

Authors:  B Hofmann; N Odum; B K Jakobsen; P Platz; L P Ryder; J O Nielsen; J Gerstoft; A Svejgaard
Journal:  Scand J Immunol       Date:  1986-06       Impact factor: 3.487

View more
  9 in total

1.  Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center.

Authors:  R D Schrier; C A Wiley; C Spina; J A McCutchan; I Grant
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis.

Authors:  I C Davis; M Girard; P N Fultz
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men.

Authors:  C J van Noesel; R A Gruters; F G Terpstra; P T Schellekens; R A van Lier; F Miedema
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

4.  Nonradioactive techniques for measurement of in vitro T-cell proliferation: alternatives to the [(3)H]thymidine incorporation assay.

Authors:  T Messele; M T Roos; D Hamann; M Koot; A L Fontanet; F Miedema; P T Schellekens; T F Rinke de Wit
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

5.  Interleukin 10 is induced by recombinant HIV-1 Nef protein involving the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway.

Authors:  E Brigino; S Haraguchi; A Koutsonikolis; G J Cianciolo; U Owens; R A Good; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

6.  Oral carriage of Candida albicans in murine AIDS.

Authors:  N Deslauriers; L Côté; S Montplaisir; L de Repentigny
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

7.  Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men.

Authors:  P T Schellekens; M T Roos; F De Wolf; J M Lange; F Miedema
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

8.  CD4+ T cells from CD4C/HIVNef transgenic mice show enhanced activation in vivo with impaired proliferation in vitro but are dispensable for the development of a severe AIDS-like organ disease.

Authors:  Xiaoduan Weng; Elena Priceputu; Pavel Chrobak; Johanne Poudrier; Denis G Kay; Zaher Hanna; Tak W Mak; Paul Jolicoeur
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.

Authors:  M Mahalingam; A Pozniak; T J McManus; D Vergani; M Peakman
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.